
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ONC | Toronto | CAD | Real-time | |
ONCY | NASDAQ | USD | Real-time | |
ONC | CBOE Canada | CAD | Real-time |
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in Calgary, Canada.
Name | Age | Since | Title |
---|---|---|---|
Angela Frances Holtham | 73 | 2014 | Independent Director |
Bernd Robert Seizinger | 69 | 2015 | Independent Director |
Wayne F. Pisano | 70 | 2013 | Chairman of the Board |
Padmanee Sharma | - | - | Member of Scientific Advisory Board |
James T. Parsons | 60 | 2022 | Independent Director |
Jared Kelly | - | 2025 | CEO & Director |
Jonathan M. N. Rigby | 57 | 2022 | Independent Director |
Deborah M. Brown | - | 2017 | Independent Director |
Patricia S. Andrews | 66 | 2024 | Independent Director |
Richard Vile | - | 2020 | Member of Scientific Advisory Board |
Dirk Arnold | - | 2024 | Member of Scientific Advisory Board |
Martine J. Piccart | - | 2017 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review